Drug
Diazoxide clinical trials
Also written Proglycem.
- studies test it
- 19
- open now
- 2
- in phase 3
- 2
- first study started
- 2004
Keep track of what changes. Save the Diazoxide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 8
- Phase 3
- 2
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 19
Columbia University (3) · Albert Einstein College of Medicine (3) · Johns Hopkins University (2) · Rijnstate Hospital (2) · Meredith Hawkins (2) · University of Dundee (1) · The Hospital for Sick Children (1) · Virginia Commonwealth University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Diazoxide is read from its arms, and is right about nine times in ten.
Testing it · 19
- Effect of Insulin Lowering on LipogenesisRecruitingPhase 1Columbia UniversityNCT07403604Written as Diazoxide Oral Suspension, 2 mg per kg per dose
- Regulation of Endogenous Glucose Production by Central KATP ChannelsRecruitingPhase 2Albert Einstein College of MedicineNCT03540758Written as Diazoxide
- Glycemic Effect of Diazoxide in NAFLDCompletedPhase 1Columbia UniversityNCT05729282Written as Diazoxide oral suspension, 1 mg per kg per dose
- Diazoxide Suppression Test P&F StudyTerminatedPhase 1Columbia UniversityNCT06606327Written as Diazoxide, 3 mg/kg per dose
- Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)TerminatedPhase 4Albert Einstein College of MedicineNCT03608163Written as Diazoxide
- Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) TrialCompletedPhase 1Johns Hopkins UniversityNCT06308107Written as IV Diazoxide
- Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to DiazoxideTerminatedPhase 2Meredith HawkinsNCT03566511Written as Diazoxide
- Central Mechanisms That Regulate Glucose Metabolism in HumansTerminatedPhase 4Meredith HawkinsNCT01028846Written as Diazoxide
- The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant RecipientsWithdrawnPhase 2Albert Einstein College of MedicineNCT03685773Written as Diazoxide
- Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary BypassWithdrawnPhase 1Johns Hopkins UniversityNCT04830982Written as IV Diazoxide
- Use of Diazoxide in Acute HypoglycaemiaCompletedPhase 4University of DundeeNCT01488136Written as Diazoxide
- Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide TherapyCompletedPhase 2The Hospital for Sick ChildrenNCT00892073Written as Diazoxide
- Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?TerminatedPhase 1/2National Institute of Mental Health (NIMH)NCT02049385Written as Diazoxide
- Insulin and Polycystic Ovary SyndromeCompletedNot applicableVirginia Commonwealth UniversityNCT00683774Written as diazoxide
- DZX Mediated Insulin Suppression in Obese MenCompletedPhase 2Rijnstate HospitalNCT00631033Written as Diazoxide
- Efficacy of Diazoxide in Type 1 DiabetesCompletedPhase 4Grill, Valdemar, M.D.NCT00131755Written as diazoxide
- Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary LesionsCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT00306683Written as DIAZOXIDE
- Diazoxide In the Management Of Hypoglycemic NeonatesStatus unknownPhase 2/3University of SaskatchewanNCT00994149Written as Diazoxide
- Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese MenCompletedPhase 2Rijnstate HospitalNCT00151684Written as Diazoxide
Given in every arm · 1 — Diazoxide is usual care beside what is tested
Codes
What other systems call Diazoxide · ClinicalTrials.gg INT007335
- MeSH (NLM) D003981DiazoxideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) O5CB12L4FNDIAZOXIDEConfirmed FDA, NLM, Wikidata
- RxNorm 3327Confirmed FDA, Wikidata
- Wikidata Q420009diazoxideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C428DiazoxideOne source FDA
- DrugBank DB01119One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003981 | Diazoxide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | O5CB12L4FN | DIAZOXIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3327 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420009 | diazoxide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C428 | Diazoxide | One source FDA |
| DrugBank | DB01119 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.